PepFellas Laboratories | Research-Grade Peptides
PEPFELLAS Laboratories • Est. 2026
Research Wiki / Peptide Profile
Peptide Profile

The Enforcer Protocol

The BPC-157 / TB-500 Recovery Duo is a widely studied two-peptide research blend pairing **Body Protection Compound-157 (BPC-157)**—a synthetic 15-amino-acid gastric pentadecapeptide—with **TB-500** ( **Thymosin Beta-4**).

1. Chemical Structure and Biochemistry

The blend combines two structurally distinct linear peptides with complementary pharmacokinetic profiles.

  • BPC-157: A 15-amino-acid sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a protective protein found in human gastric juice. Its proline-rich structure grants high stability even in acidic environments.
  • TB-500: In research catalogs, TB-500 refers either to the 7-amino-acid active actin-binding fragment (Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, CAS 885340-08-9) or the full-length 43-amino-acid N-acetylated Thymosin Beta-4 polypeptide (CAS 77591-33-4). Both share the conserved LKKTET actin-sequestering domain.

2. Mechanism of Action

The two peptides act on distinct, non-overlapping cellular repair pathways that converge on accelerated wound healing:

  • Angiogenesis & Nitric Oxide Modulation (BPC-157): BPC-157 upregulates Vascular Endothelial Growth Factor (VEGF) and activates the FAK-paxillin and eNOS/nitric oxide pathways, promoting new blood vessel formation (angiogenesis) and upregulating growth hormone receptor expression on tendon fibroblasts.
  • Actin Sequestration & Cell Migration (TB-500): TB-500 binds globular actin (G-actin), regulating cytoskeletal polymerization so endothelial cells, keratinocytes, and progenitor cells can rapidly migrate to sites of tissue injury. It also reduces fibrotic scar tissue formation.

3. Research and Applications

Both compounds are strictly preclinical/investigational in Western medicine and are prohibited in tested athletic competition (WADA).

  • Musculoskeletal Repair: Extensively investigated in rodent models of Achilles tendon transection, medial collateral ligament tears, and skeletal muscle crush injuries.
  • Vascular & Gastrointestinal Integrity: BPC-157 is additionally studied for mucosal healing in inflammatory bowel models and counteracting NSAID-induced gut lesions, while Thymosin $\beta_4$ derivatives are explored in corneal and myocardial repair.

Note: Neither BPC-157 nor TB-500 is FDA-approved for human clinical use.

Tags: BPC-157 TB-500 Thymosin-Beta-4 Recovery-Duo pentadecapeptide Ac-LKKTETQ angiogenesis actin-sequestration tendon-repair regenerative-research